Ulf Lindström
Affiliated to Research
Department of Rheumatology a Inflammation-
Incident gout and risk of first-time acute coronary syndrome: a prospective, population-based, cohort study in
Sweden
Panagiota Drivelegka, Lennart T. H. Jacobsson, Ulf Lindström, Karin Bengtsson, Mats Dehlin
Arthritis Care and Research - 2023 -
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide
study
Ulf Lindström, D. di Giuseppe, S. Exarchou, G. M. Alenius, T. Olofsson, Eva Klingberg, Lennart T. H. Jacobsson, J. Askling, J. K. Wallman
Rmd Open - 2023 -
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics
registries
B. Glintborg, D. Di Giuseppe, J. K. Wallman, D. C. Nordstrom, B. Gudbjornsson, M. L. Hetland, J. Askling, G. Grondal, T. Sokka, S. A. Provan, B. Michelsen, E. K. Kristianslund, L. Dreyer, T. J. Love, Ulf Lindström
Annals of the Rheumatic Diseases - 2023 -
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS
programme
T. Frisell, H. Bower, M. Morin, E. Baecklund, D. Di Giuseppe, B. Delcoigne, N. Feltelius, Helena Forsblad d'Elia, E. Lindqvist, Ulf Lindström, J. Askling
Annals of the Rheumatic Diseases - 2023 -
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA
collaboration
L. M. Ørnbjerg, L. Linde, S. Georgiadis, S. H. Rasmussen, Ulf Lindström, J. Askling, B. Michelsen, D. D. Giuseppe, J. K. Wallman, K. Pavelka, J. Závada, M. J. Nissen, G. T. Jones, H. Relas, L. Pirilä, M. Tomšič, Z. Rotar, A. J. Geirsson, B. Gudbjornsson, E. K. Kristianslund, I. van sder Horst-Bruinsma, A. G. Loft, K. Laas, F. Iannone, A. Corrado, A. Ciurea, M. J. Santos, H. Santos, C. Codreanu, N. Akkoc, O. S. Gunduz, B. Glintborg, M. Østergaard, M. L. Hetland
Seminars in Arthritis and Rheumatism - 2022 -
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register
data
A. Barbulescu, J. Askling, K. Chatzidionysiou, Helena Forsblad d'Elia, A. Kastbom, Ulf Lindström, C. Turesson, T. Frisell
Rheumatology - 2022 -
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology
registries
D. Di Giuseppe, Ulf Lindström, K. Aaltonen, H. Relas, S. Provan, B. Gudbjornsson, M. L. Hetland, J. Askling, M. Kauppi, A. J. Geirsson, K. Chatzidionysiou, T. S. Jorgensen, L. Dreyer, B. Michelsen, Lennart T. H. Jacobsson, B. Glintborg
Rheumatology - 2022 -
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic
countries
B. Glintborg, D. Di Giuseppe, J. K. Wallman, S. A. Provan, D. Nordstrom, A. M. Hokkanen, J. Osterlund, E. Kristianslund, T. K. Kvien, B. Gudbjornsson, M. L. Hetland, B. Michelsen, Lennart T. H. Jacobsson, J. Askling, Ulf Lindström
Rheumatology - 2022 -
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient
Register
J. K. Wallman, G. M. Alenius, Eva Klingberg, V. Sigurdardottir, S. Wedren, S. Exarchou, Ulf Lindström, D. Di Giuseppe, J. Askling, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2022 -
Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort
study
M. Morin, K. Hellgren, Ulf Lindström, T. Frisell
Scandinavian Journal of Rheumatology - 2022 -
Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center
experience.
Emanuele Bobbio, Clara Hjalmarsson, Marie Björkenstam, Christian Lars Polte, Anders Oldfors, Ulf Lindström, Pia Dahlberg, Sven-Erik Bartfay, Piotr Szamlewski, Amar Taha, Egidija Sakiniene, Kristjan Karason, Niklas Bergh, Entela Bollano
BMC cardiovascular disorders - 2022 -
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial
spondylarthritis
M. Nissen, B. Delcoigne, D. Di Giuseppe, Lennart T. H. Jacobsson, M. L. Hetland, A. Ciurea, L. Nekvindova, F. Iannone, N. Akkoc, T. Sokka-Isler, K. M. Fagerli, M. J. Santos, C. Codreanu, M. Pombo-Suarez, Z. Rotar, B. Gudbjornsson, I. Van der Horst-Bruinsma, A. G. Loft, B. Moller, H. Mann, F. Conti, G. Y. Cetin, H. Relas, B. Michelsen, P. A. Ribeiro, R. Ionescu, C. Sanchez-Piedra, M. Tomsic, A. J. Geirsson, J. Askling, B. Glintborg, Ulf Lindström
Rheumatology - 2022 -
Lifestyle Factors and Disease Activity Over Time in Early Axial Spondyloarthritis: The SPondyloArthritis Caught Early (SPACE)
Cohort
S. Exarchou, C. Turesson, Ulf Lindström, R. Ramonda, R. B. Landewe, H. Dagfinrud, F. Van Gaalen, D. Van der Heijde, Lennart T. H. Jacobsson
Journal of Rheumatology - 2022 -
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment
Courses
B. Glintborg, Ulf Lindström, D. Di Giuseppe, S. A. Provan, B. Gudbjornsson, M. L. Hetland, B. Michelsen, J. K. Wallman, K. Aaltonen, A. M. Hokkanen, D. Nordstrom, T. S. Jorgensen, R. L. Hansen, A. J. Geirsson, K. L. Gron, N. S. Krogh, J. Askling, L. E. Kristensen, Lennart T. H. Jacobsson
Arthritis Care & Research - 2022 -
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in
Sweden
D. Di Giuseppe, Ulf Lindström, H. Bower, B. Delcoigne, T. Frisell, K. Chatzidionysiou, C. Sjowall, E. Lindqvist, J. Askling
Rheumatology - 2021 -
Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA-results from a national register-based cohort study.
Reply.
Karin Bengtsson, Helena Forsblad d'Elia, Anna Deminger, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart Jacobsson
Rheumatology (Oxford, England) - 2021 -
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care
provision
H. Bower, T. Frisell, D. di Giuseppe, B. Delcoigne, G. M. Ahlenius, E. Baecklund, K. Chatzidionysiou, N. Feltelius, Helena Forsblad d'Elia, A. Kastbom, L. Klareskog, E. Lindqvist, Ulf Lindström, C. Turesson, C. Sjowall, J. Askling, Artis Study Grp Artis Study Grp
Rmd Open - 2021 -
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy
matter?
Ulf Lindström, Karin Bengtsson, T. Olofsson, D. Di Giuseppe, B. Glintborg, Helena Forsblad d'Elia, Lennart T. H. Jacobsson, J. Askling
Annals of the Rheumatic Diseases - 2021 -
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic
arthritis
Ulf Lindström, B. Glintborg, D. Di Giuseppe, T. S. Jorgensen, B. Gudbjornsson, K. L. Gron, S. A. Provan, B. Michelsen, M. L. Hetland, J. K. Wallman, D. Nordstrom, N. Trokovic, T. J. Love, N. S. Krogh, J. Askling, Lennart T. H. Jacobsson, L. E. Kristensen
Rheumatology - 2021 -
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort
study.
Karin Bengtsson, Helena Forsblad d'Elia, Anna Deminger, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Rheumatology (Oxford, England) - 2021 -
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort
study.
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling
Annals of the rheumatic diseases - 2021 -
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA
collaboration
Ulf Lindström, D. Di Giuseppe, B. Delcoigne, B. Glintborg, B. Möller, A. Ciurea, M. Pombo-Suarez, C. Sanchez-Piedra, K. Eklund, H. Relas, B. Gudbjornsson, T. J. Love, G. T. Jones, C. Codreanu, R. Ionescu, L. Nekvindova, J. Závada, N. Atas, S. Yolbas, K. M. Fagerli, B. Michelsen, Rotar, Rotar,, M. Tomšič, F. Iannone, M. J. Santos, P. Avila-Ribeiro, L. M. Ørnbjerg, M. Østergaard, Lennart T. H. Jacobsson, J. Askling, M. J. Nissen
Annals of the Rheumatic Diseases - 2021 -
Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing
spondylitis
A. Sodergren, J. Askling, Karin Bengtsson, Helena Forsblad d'Elia, T. Jernberg, Ulf Lindström, L. Ljung, A. Mantel, Lennart T. H. Jacobsson
Clinical Rheumatology - 2021 -
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA
collaboration
B. Michelsen, Ulf Lindström, C. Codreanu, A. Ciurea, J. Zavada, A. G. Loft, M. Pombo-Suarez, F. Onen, T. K. Kvien, Z. Rotar, M. J. Santos, F. Iannone, A. M. Hokkanen, B. Gudbjornsson, J. Askling, R. Ionescu, M. J. Nissen, K. Pavelka, C. Sanchez-Piedra, S. Akar, J. Sexton, M. Tomsic, H. Santos, M. Sebastiani, J. Österlund, A. J. Geirsson, G. Macfarlane, I. van der Horst-Bruinsma, S. Georgiadis, C. H. Brahe, L. M. Ørnbjerg, M. L. Hetland, M. Østergaard
RMD open - 2020 -
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with
spondyloarthritis
Ulf Lindström, B. Glintborg, D. Di Giuseppe, D. Nordstrom, S. A. Provan, B. Gudbjornsson, J. Askling, M. L. Hetland, K. Aaltonen, N. S. Krogh, A. J. Geirsson, Lennart T. H. Jacobsson
RMD Open - 2019 -
Uptake of rheumatology biosimilars in the absence of forced
switching
D. Di Giuseppe, T. Frisell, S. Ernestam, Helena Forsblad d'Elia, E. Lindqvist, Ulf Lindström, C. Sjowall, J. Askling
Expert Opinion on Biological Therapy - 2018 -
Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological
registries
B. Glintborg, Ulf Lindström, K. Aaltonen, E. K. Kristianslund, B. Gudbjornsson, K. Chatzidionysiou, J. Askling, D. Nordstrom, M. L. Hetland, D. Di Giuseppe, L. Dreyer, L. E. Kristensen, T. S. Jorgensen, K. Eklund, G. Grondal, S. Ernestam, J. Joensuu, M. R. K. Tormanen, H. Skydsgaard, J. Hagfors, T. K. Kvien, E. Lie, K. Fagerli, A. J. Geirsson, H. Jonsson, S. A. Provan, N. S. Krogh, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2018 -
Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from
Sweden
Karin Bengtsson, Helena Forsblad d'Elia, Elisabeth Lie, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2018 -
Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort
study
Anton J. Landgren, Lennart T. H. Jacobsson, Ulf Lindström, Tatiana Zverkova Sandström, Panagiota Drivelegka, Lena Björkman, E. Fjellstedt, Mats Dehlin
Arthritis Research & Therapy - 2017 -
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics
register
Elisabeth Lie, Ulf Lindström, Tatiana Zverkova Sandström, I. C. Olsen, H. Forsblad-d'Elia, J. Askling, M. C. Kapetanovic, L. E. Kristensen, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2017 -
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort
study.
Karin Bengtsson, Helena Forsblad d'Elia, Elisabeth Lie, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Arthritis research & therapy - 2017 -
Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control
study
Ulf Lindström, S. Exarchou, Elisabeth Lie, Mats Dehlin, Helena Forsblad d'Elia, J. Askling, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2016 -
Axial spondyloarthritis - with special emphasis on prevalence, perceived health and
predictors
Ulf Lindström
2016 -
Mortality in ankylosing spondylitis: results from a nationwide population-based
study
S. Exarchou, Elisabeth Lie, Ulf Lindström, J. Askling, Helena Forsblad d'Elia, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2016 -
Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based
study
Ulf Lindström, A. Bremander, E. Haglund, Stefan Bergman, I. F. Petersson, Lennart T. H. Jacobsson
Bmc Musculoskeletal Disorders - 2016 -
Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national
registers
Ulf Lindström, Helena Forsblad d'Elia, J. Askling, L. E. Kristensen, Elisabeth Lie, S. Exarchou, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2016 -
Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient
Register
Ulf Lindström, S. Exarchou, V. Sigurdardottir, B. Sundström, J. Askling, J. K. Eriksson, Helena Forsblad d'Elia, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2015 -
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register
study
S. Exarchou, Ulf Lindström, J. Askling, J. K. Eriksson, Helena Forsblad d'Elia, M. Neovius, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2015